Dr Paola Villanueva
Dr Paola Villanueva
Details
Role
Honorary Fellow
Research area
Infection, Immunity and Global Health
Group
Infectious Diseases
Contact
Email
show email address
Dr Paola Villanueva is a consultant paediatrician and post-doctoral researcher in the Infectious Diseases Research Group at the Murdoch Children’s Research Institute. She is also a lecturer in medical education and paediatric teaching fellow at the University of Melbourne, and has completed a Simulation Education Fellowship at The Royal Children’s Hospital.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Dr Paola Villanueva is a consultant paediatrician and post-doctoral researcher in the Infectious Diseases Research Group at the Murdoch Children’s Research Institute. She is also a lecturer in medical education and paediatric teaching fellow at the...
Dr Paola Villanueva is a consultant paediatrician and post-doctoral researcher in the Infectious Diseases Research Group at the Murdoch Children’s Research Institute. She is also a lecturer in medical education and paediatric teaching fellow at the University of Melbourne, and has completed a Simulation Education Fellowship at The Royal Children’s Hospital.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Her PhD research focuses on evaluating the safety of BCG vaccination and how to prevent adverse events. Her work involves vaccine safety surveillance within a large international clinical trial, collaborating with research centres in Australia, Brazil, the UK, the Netherlands and Spain.
Top Publications
- Messina, NL, Germano, S, Chung, AW, van de Sandt, CE, Stevens, NE, Allen, LF, Bonnici, R, Croda, J, Counoupas, C, Grubor-Bauk, B, et al. Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination.. Clin Transl Immunology 14(1) : e70023 2025 view publication
- Villanueva, P, McDonald, E, Croda, J, Croda, MG, Dalcolmo, M, Dos Santos, G, Jardim, B, Lacerda, M, Lynn, DJ, Marshall, H, et al. Factors influencing adverse events following COVID-19 vaccination.. Hum Vaccin Immunother 20(1) : 2323853 2024 view publication
- Villanueva, P, Crawford, NW, Croda, MG, Croda, J, Dalcolmo, M, Jardim, BA, Jardim, TDAP, Marshall, H, Prat-Aymerich, C, Sawka, A, et al. Accelerated Bacille Calmette-Guérin reactions: More than meets the eye.. Heliyon 10(13) : e32510 2024 view publication
- Pittet, LF, Messina, NL, McDonald, E, Orsini, F, Barry, S, Bonten, M, Campbell, J, Croda, J, Croda, MG, Dalcolmo, M, et al. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.. EClinicalMedicine 72: 102616 2024 view publication
- Messina, NL, Germano, S, McElroy, R, Bonnici, R, Grubor-Bauk, B, Lynn, DJ, McDonald, E, Nicholson, S, Perrett, KP, Pittet, LF, et al. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.. EBioMedicine 103: 105100 2024 view publication
Page 1 of 7
